Singapore Chung Hwa Medical Institution, Singapore, Singapore.
Singapore College of Traditional Chinese Medicine, Singapore, Singapore.
JMIR Res Protoc. 2024 Sep 12;13:e56024. doi: 10.2196/56024.
Diabetes and prediabetes are diagnosed differentially by Western and Chinese medicine. While Western medicine uses objective laboratory analysis of biochemical parameters to define the severity of diabetes and prediabetes, Chinese medicine uses a comprehensive approach that integrates observation, inquiry, pulse palpation, and tongue diagnosis. The medical information collected is then categorized into different syndromes. However, traditional methods of pulse and tongue diagnoses used to determine syndrome differentiation are highly subjective and skill dependent.
This study aims to identify the gap in conventional traditional Chinese medicine (TCM) diagnostic techniques for syndrome differentiation analysis using contemporary diagnostic devices. We devised a protocol for a nonrandomized, exploratory, observational case-control study with equal allocations in 5 arms to investigate the syndrome differentiation of diabetes and prediabetes. We hypothesize that the TCM syndrome differentiation of diabetes and prediabetes in the tropical climate may differ from that defined based on the Chinese demographic. We also speculate that the high-frequency spectral energy may reflect a difference in pulse wave intensity and density between the healthy and diabetes groups.
A total of 250 eligible participants will be equally assigned to 1 of 5 arms (healthy or subhealthy, prediabetes, diabetes, prediabetes with hypertension and dyslipidemia, and diabetes with hypertension and dyslipidemia). Participants aged 21-75 years, of any sex or race, and have been diagnosed with diabetes (fasting plasma glucose [FPG] of 7 mmol/L, or 2-hour plasma glucose [2hPG] of 11.1 mmol/L) or prediabetes (impaired FPG of 6.1-6.9 mmol/L, or impaired glucose tolerance with an 2hPG of 7.8-11 mmol/L) will be included. The Health Evaluation Questionnaire, Physical Activity Questionnaire, sugar intake assessment, Constitution in Chinese Medicine Questionnaire, radial pulse diagnosis, and tongue diagnosis will be performed in a single visit. ANOVA for continuous data and chi-square tests of independence will be used for categorical data assessments, with a level of P<.05 considered significant.
The recruitment is in progress. We anticipate that the study will conclude in June 2025. As of July 15, 2024, we have enrolled 140 individuals.
To the best of our knowledge, this is the first study to use contemporary TCM diagnostic instruments to map expert and empirical knowledge of TCM to its scientific equivalents for the purpose of evaluating the syndrome differentiation of diabetes. We designed this protocol with the exploratory goal to examine objectively the syndrome differentiation of patients with diabetes and those with prediabetes using TCM diagnostic technologies. The data collected and evaluated under standardized conditions using these contemporary diagnostic devices will exhibit a higher degree of stability, hence yielding dependable and unbiased results for syndrome differentiation. Thus, our findings may potentially increase the accuracy of identification, diagnosis, treatment, and prevention of diabetes and prediabetes through a system of targeted treatment.
ClinicalTrials.gov NCT05563090; https://clinicaltrials.gov/ct2/show/NCT05563090.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/56024.
糖尿病和糖尿病前期的诊断在西方医学和中医学中存在差异。西医使用生化参数的客观实验室分析来定义糖尿病和糖尿病前期的严重程度,而中医则采用综合方法,将观察、询问、脉象和舌诊相结合。收集的医学信息随后被分类为不同的证候。然而,传统的脉象和舌诊方法用于确定证候分类是高度主观和依赖技能的。
本研究旨在利用现代诊断设备,确定传统中医(TCM)诊断技术在证候分类分析中的差距。我们制定了一项非随机、探索性、观察性病例对照研究方案,采用 5 组均等分配的方法,对糖尿病和糖尿病前期的证候分类进行研究。我们假设热带气候下的糖尿病和糖尿病前期的 TCM 证候分类可能与基于中国人口的定义不同。我们还推测高频谱能量可能反映了健康组和糖尿病组之间脉搏波强度和密度的差异。
共有 250 名符合条件的参与者将被平均分配到 5 个组之一(健康或亚健康、糖尿病前期、糖尿病、高血压伴血脂异常的糖尿病前期和高血压伴血脂异常的糖尿病)。年龄在 21-75 岁之间、任何性别或种族、并被诊断为糖尿病(空腹血糖 [FPG] 为 7mmol/L,或 2 小时血糖 [2hPG] 为 11.1mmol/L)或糖尿病前期(空腹血糖受损 [FPG] 为 6.1-6.9mmol/L,或糖耐量受损,2hPG 为 7.8-11mmol/L)的参与者将被纳入研究。将在单次就诊中进行健康评估问卷、体力活动问卷、糖摄入量评估、中医体质问卷、桡动脉诊断和舌诊。连续数据采用方差分析,分类数据采用卡方检验的独立性检验,P<.05 为差异有统计学意义。
正在进行招募。我们预计研究将于 2025 年 6 月结束。截至 2024 年 7 月 15 日,我们已经招募了 140 人。
据我们所知,这是第一项使用现代中医诊断仪器将中医的专家和经验知识映射到其科学等价物的研究,目的是评估糖尿病的证候分类。我们设计了本方案,具有探索性目标,使用中医诊断技术客观地检查糖尿病患者和糖尿病前期患者的证候分类。在使用这些现代诊断设备的标准化条件下收集和评估的数据将表现出更高的稳定性,从而为证候分类提供可靠和无偏倚的结果。因此,我们的发现可能通过靶向治疗系统提高糖尿病和糖尿病前期的识别、诊断、治疗和预防的准确性。
ClinicalTrials.gov NCT05563090; https://clinicaltrials.gov/ct2/show/NCT05563090。
国际注册报告标识符(IRRID):DERR1-10.2196/56024。